Iofina shares decline as CEO takes leave of absence

Shares in Iofina, a specialist in the exploration and production of iodine and specialty chemical iodine derivatives, dropped nearly 10 per cent on Monday morning after the group announced its Chief Executive Officer, Secretary and President, is taking a leave of absence for health reasons.

Shares in Iofina, a specialist in the exploration and production of iodine and specialty chemical iodine derivatives, dropped nearly 10 per cent on Monday morning after the group announced its Chief Executive Officer, Secretary and President, is taking a leave of absence for health reasons.

The director will return to his role once his treatment is completed, the firm added.

Non-Executive Chairman Dr. Chris Fay will assume the role of Executive Chairman, while Non-Executive Director Stuart Eaton will assume the role of Executive Operations Officer. Jeff Ploen will remain Non-Executive Deputy Chairman.

Fay said: "We wish Lance and his family the very best at this difficult time and look forward to welcoming him back, fit and well in due course."

The group added that trading continues in line with the board's expectations and the company expects to be in a position to announce its final results for the year ended December 31st 2012 in the near term.

The share price fell 9.51% to 195p by 08:43 Monday.

NR

Recommended

Share tips of the week – 21 January
Share tips

Share tips of the week – 21 January

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
21 Jan 2022
Seven cheap defence stocks to buy now
Share tips

Seven cheap defence stocks to buy now

We’ve got used to a world without war between major powers, but that era is coming to an end as Russia threatens Ukraine and China eyes Taiwan. Buy de…
21 Jan 2022
Invest in VCTs: tax-free investments set to break records
Investment strategy

Invest in VCTs: tax-free investments set to break records

Generous tax breaks make VCTs – venture capital funds – an attractive supplement to pensions.
21 Jan 2022
HubSpot: a tech stock set to tumble
Trading

HubSpot: a tech stock set to tumble

US tech stocks have had a fantastic couple of years. But this year is unlikely to be so bullish for high-fliers that can’t turn big profits.
18 Jan 2022

Most Popular

Ask for a pay rise – everyone else is
Inflation

Ask for a pay rise – everyone else is

As inflation bites and the labour market remains tight, many of the nation's employees are asking for a pay rise. Merryn Somerset Webb explains why yo…
17 Jan 2022
Temple Bar’s Ian Lance and Nick Purves: the essence of value investing
Investment strategy

Temple Bar’s Ian Lance and Nick Purves: the essence of value investing

Ian Lance and Nick Purves of the Temple Bar investment trust explain the essence of “value investing” – buying something for less than its intrinsic v…
14 Jan 2022
US inflation is at its highest since 1982. Why aren’t markets panicking?
Inflation

US inflation is at its highest since 1982. Why aren’t markets panicking?

US inflation is at 7% – the last time it was this high interest rates were at 14%. But instead of panicking, markets just shrugged. John Stepek explai…
13 Jan 2022